# 10x Genomics (TXG) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/TXG
## Company Profile
- Ticker: TXG
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Life Science Tools
## Stock Data
- Close: 65.6 USD
- Market cap: 3898824564.19 USD
- Last updated: 2026-09-08
## Business Overview
10x Genomics is a life sciences tools company focused on single-cell and spatial biology technologies. Its products help researchers study biology at high resolution and support discovery across genomics and translational research.
## Why The Stock Is Moving

As of Sep 8, 2026, TXG closed up 4.71% at $65.60. No new same-company headline was identified in the current news window.

## Geographic Base

Headquartered in the United States and listed on NASDAQ, 10x Genomics has a global footprint in research tools. It sits in the biotech infrastructure layer rather than therapeutics.

## Business Model

The company generates revenue from instruments, consumables, and workflow technologies used in genomics research. Investors watch academic and biopharma spending, product adoption, and the pace of platform utilization.

## Landscape Position

10x Genomics is one of the most important tools names in modern biology because it powers discovery across the life sciences. It is not a drug company, but it is highly relevant to biotech research spending.

## Future Catalysts

- 10x Genomics’ catalysts are Xenium adoption, Chromium demand, and any evidence that consumables recovery is finally broadening. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.

## Recent News
- 2021-08-31 20:05 EST — [10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference](https://biopharmsignal.com/news/TXG/10x-genomics-to-present-at-the-morgan-stanley-19th-annual-global-healthcare-conf-0ad7c5ca) — Source: 10x Genomics
- 2021-08-06 12:00 EST — [10x Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit](https://biopharmsignal.com/news/TXG/10x-genomics-to-present-at-the-ubs-genomics-2-0-and-medtech-innovations-summit-06bd0179) — Source: 10x Genomics
- 2021-08-04 20:05 EST — [10x Genomics Reports Second Quarter 2021 Financial Results](https://biopharmsignal.com/news/TXG/10x-genomics-reports-second-quarter-2021-financial-results-dc767083) — Source: 10x Genomics
- 2021-07-27 10:30 EST — [10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad](https://biopharmsignal.com/news/TXG/10x-genomics-signs-global-patent-cross-license-agreement-with-bio-rad-6b8821a8) — Source: 10x Genomics
- 2021-07-14 12:00 EST — [10x Genomics Introduces New Chromium X Series for Single Cell Analysis](https://biopharmsignal.com/news/TXG/10x-genomics-introduces-new-chromium-x-series-for-single-cell-analysis-e0316c11) — Source: 10x Genomics